Antibacterial Agents TRIZ Cases

Non-rinsing eyelid foam eradicates bacteria and reduces inflammation to manage blepharitis.

Segmented acylguanidine bile acid analogs enhance therapeutic effectiveness against metabolic disorders while managing structural complexity.

Sterically hindered acyl groups protect macrolides during synthesis to enhance yield and purity.

Synthesizing enantiomerically pure chlorin e4 sodium via parameter changes overcomes low singlet oxygen quantum yield in conventional photosensitizers.

Lethal factor N domain transports target antigens into the cytosol without protective antigen, resolving inflammation risks from traditional adjuvants.

Iron-regulated Yersinia polypeptides elicit targeted immunity, resolving inadequate pneumonic plague protection in current vaccines.

Plant-derived bio-reduction synthesizes 7-13 nm silver nanoparticles, resolving environmental hazards and dosage precision issues in nanoparticle manufacturing.

Polyethylene glycol conjugation improves K-252a solubility and reduces systemic toxicity during topical administration.

Adhesive patch saturates permeable layer with antimicrobial composition to prevent resistant bacteria while maintaining antiseptic effectiveness.

A blunt end 5′ triphosphate oligonucleotide activates the RIG-I receptor to trigger antiviral immune responses.

Specific oligonucleotide sequences inhibit TLR9 activation and reduce excessive cytokine levels to treat immune-mediated disorders.

Cyclic constraints stabilize beta-hairpin peptidomimetics, enabling selective membrane permeabilization against resistant Gram-negative bacteria.

Hydrophilic linkers with phosphinate groups enable high drug loading on antibodies.

A nitrogen heterocyclic compound resists indoleamine 2,3-dioxygenase activity to block kynurenine synthesis.

Combining plant essential oils with polyionic enhancers boosts antimicrobial efficacy through improved cellular uptake.

A recombinant Listeria strain expresses tumor-specific and angiogenic polypeptides to induce a synergistic immune response.

Hot melt extrusion eliminates solvent drying time while maintaining homogeneous surface quality for stable drug delivery.

Combining kuraridin with epicatechin gallate overcomes methicillin-resistant Staphylococcus aureus resistance while enhancing conventional antibiotic efficacy.

Fibers with glucose oxidase convert substrate to release hydrogen peroxide, sustaining antimicrobial activity against biofilms without honey variability.

A carvacrol and thymol composition treats salmonid infections by directly inhibiting bacterial growth and viral replication.

Flagellin activates Toll-like receptor 5 to modulate immune responses, reducing graft-versus-host disease symptoms while preserving anti-viral immunity.

Hydroxamic acid derivatives neutralize anthrax lethal factor by binding its active site zinc, preventing MAPKK cleavage and toxin accumulation.

Anti-malarial agents target the DosRS system to disrupt biofilms, addressing low cure rates and drug tolerance in non-tuberculous mycobacterial infections.

EthR inhibitors modulate enzyme expression to boost ethionamide efficacy against resistant tuberculosis while reducing side effects.

Multi-gene deletions in live attenuated Shigella vaccine strains eliminate fever-inducing pyrogenic factors while maintaining immunogenicity.

Formula I compounds modulate the transrepression pathway to improve central nervous system therapeutic effects while reducing systemic side effects.

A carrier matrix of non-human mammal components combined with specific polyclonal antibodies provides broad-spectrum pathogen neutralization.

GnRH analogs restore MHC class II expression on antigen-presenting cells, enabling T cell activation against intracellular pathogens that evade detection.

A crosslinking polysaccharide derivative forms a biodegradable gel to sustain drug concentration in blood.

A catheter locking solution combines local anesthetics like dibucaine with a viscosifying agent to maintain patency.

Segmented synthetic MeOPN antigens resolve vaccine manufacturing complexity while eliciting protective antibodies against Campylobacter jejuni.

Anhydrous silver dihydrogen citrate in a hydrogel matrix delivers direct antimicrobial protection without reconstitution.

Protective groups mask amino groups to resolve site-selective conjugation difficulties in Shigella sonnei vaccine synthesis.

Modified isoquinolone compounds reduce myosin light chain phosphatase phosphorylation, improving hypertension management.

Hydantoin compounds block TNF-alpha release and cartilage degradation by simultaneously inhibiting MMPs, ADAMs, and TACE enzymes.

Hydrolytic and oxidative enzymes degrade airway biofilm matrices, restoring antibiotic potency against resistant Mycoplasma pneumoniae infections.

Protecting groups guide chemical sulphation to deposit mono-sulphated groups at positions 4 or 6, replicating natural patterns for bioavailability.

Conjugating hemin with amino acids resolves water insolubility while maintaining activity against resistant strains like MRSA.

A chimeric recombinant protein combines epitopes from multiple Borrelia strains to create a polyvalent vaccine candidate.

Antibodies targeting Staphylococcus aureus LukAB toxin neutralize cytotoxicity and reduce bacterial loads, addressing rising antibiotic resistance.

Tetrazolyl metalloenzyme inhibitors balance potency and selectivity by forming specific chemical interactions that minimize off-target toxicity.

A gold nanoparticle-aptamer conjugate delivers antimicrobial peptides into target cells via molecular recognition and cellular uptake mechanisms.

Carrier protein conjugation reverses alpha-glycosylceramide-induced antibody suppression, enhancing immunogenicity for saccharide vaccines.

Optimized imidazoquinoline structures achieve dual PI3-kinase and mTOR inhibition, addressing dysregulated signaling in muscle wasting.

Engineered single-chain variable fragment libraries amplify canine immunoglobulin chains to generate targeted therapeutic agents.

Optimized cytidine-to-uridine ratios create a rugged double-stranded RNA that resists hydrolysis and branching, boosting interferon induction efficacy.

Tricyclic compounds inhibit TNF-alpha synthesis and PDE4 activity to address underlying inflammatory pathology beyond symptomatic relief.

Isolated MtrE peptides target the efflux pump system to overcome antibiotic resistance in gonorrhea prevention.

Formula I compounds inhibit 11β-HSD1 enzyme activity to regulate cortisol levels, addressing obesity and metabolic syndrome.